Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review.
Betacoronavirus
/ immunology
COVID-19
Coronavirus Infections
/ drug therapy
Exercise
Humans
Immunity, Cellular
/ immunology
Infection Control
/ methods
Oxygen
/ metabolism
Pandemics
/ prevention & control
Pneumonia, Viral
/ immunology
Respiratory System
/ immunology
SARS-CoV-2
COVID-19 Drug Treatment
Aerobic capacity
COVID-19
Immune system
Respiratory system
Journal
Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250
Informations de publication
Date de publication:
Historique:
received:
11
04
2020
revised:
25
04
2020
accepted:
25
04
2020
pubmed:
11
5
2020
medline:
29
7
2020
entrez:
11
5
2020
Statut:
ppublish
Résumé
COVID-19 is a public world crisis, however, it is a self-limited infection. In COVID-19, the strength of immune and respiratory systems is a critical element. Thus, this review was conducted to demonstrate the short and long term effects of increasing the aerobic capacity on increasing the function and strength of immune and respiratory systems, particularly those essential for overcoming COVID-19 infections and associated disorders. This review was carried out by searching in Web of Science, Scopus, EBSCO, Medline databases. The search was conducted over clinical trials and literature and systematic reviews on the effects of increasing the aerobic capacity on the function and strength of specific immune and respiratory elements essential for overcoming COVID-19 infections. This review found that increasing the aerobic capacity could produce short-term safe improvements in the function of immune and respiratory systems, particularly those specific for COVID-19 infections. This could be mainly produced through three mechanisms. Firstly, it could improve immunity by increasing the level and function of immune cells and immunoglobulins, regulating CRP levels, and decreasing anxiety and depression. Secondly, it could improve respiratory system functions by acting as an antibiotic, antioxidant, and antimycotic, restoring normal lung tissue elasticity and strength. Lastly, it could act as a protective barrier to decrease COVID-19 risk factors, which helps to decrease the incidence and progression of COVID-19. This review summarizes that increasing the aerobic capacity is recommended because it has potential of improving immune and respiratory functions which would help counter COVID-19.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
COVID-19 is a public world crisis, however, it is a self-limited infection. In COVID-19, the strength of immune and respiratory systems is a critical element. Thus, this review was conducted to demonstrate the short and long term effects of increasing the aerobic capacity on increasing the function and strength of immune and respiratory systems, particularly those essential for overcoming COVID-19 infections and associated disorders.
METHODS
METHODS
This review was carried out by searching in Web of Science, Scopus, EBSCO, Medline databases. The search was conducted over clinical trials and literature and systematic reviews on the effects of increasing the aerobic capacity on the function and strength of specific immune and respiratory elements essential for overcoming COVID-19 infections.
RESULTS
RESULTS
This review found that increasing the aerobic capacity could produce short-term safe improvements in the function of immune and respiratory systems, particularly those specific for COVID-19 infections. This could be mainly produced through three mechanisms. Firstly, it could improve immunity by increasing the level and function of immune cells and immunoglobulins, regulating CRP levels, and decreasing anxiety and depression. Secondly, it could improve respiratory system functions by acting as an antibiotic, antioxidant, and antimycotic, restoring normal lung tissue elasticity and strength. Lastly, it could act as a protective barrier to decrease COVID-19 risk factors, which helps to decrease the incidence and progression of COVID-19.
CONCLUSION
CONCLUSIONS
This review summarizes that increasing the aerobic capacity is recommended because it has potential of improving immune and respiratory functions which would help counter COVID-19.
Identifiants
pubmed: 32388326
pii: S1871-4021(20)30103-X
doi: 10.1016/j.dsx.2020.04.038
pmc: PMC7186129
pii:
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
489-496Informations de copyright
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Références
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Immunol Cell Biol. 2000 Oct;78(5):502-9
pubmed: 11050533
Diabetes Care. 2013 Mar;36(3):537-42
pubmed: 23172972
Clin Exp Immunol. 2009 Sep;157 Suppl 1:12-6
pubmed: 19630864
Immunol Allergy Clin North Am. 2011 Feb;31(1):133-40
pubmed: 21094928
Biochem J. 2005 Nov 15;392(Pt 1):135-43
pubmed: 16048439
J Am Geriatr Soc. 2005 Nov;53(11):2037-8
pubmed: 16274398
J Immunol Res. 2019 Apr 7;2019:6491738
pubmed: 31089478
Clin Microbiol Rev. 2015 Apr;28(2):465-522
pubmed: 25810418
PLoS One. 2012;7(12):e49937
pubmed: 23227155
Vaccine. 2005 Apr 8;23(20):2565-72
pubmed: 15780438
Anxiety Stress Coping. 2008 Apr;21(2):117-28
pubmed: 18350391
BMC Pulm Med. 2014 Oct 17;14:160
pubmed: 25326140
Blood Press Monit. 2013 Dec;18(6):342-5
pubmed: 24192849
Depress Anxiety. 2013 Apr;30(4):362-73
pubmed: 23300122
Front Physiol. 2017 Oct 31;8:856
pubmed: 29163201
Sports Med. 2006;36(2):109-16
pubmed: 16464120
J Appl Physiol (1985). 2014 Nov 1;117(9):998-1007
pubmed: 25190745
J Card Fail. 2007 Mar;13(2):100-7
pubmed: 17395049
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Diabetes Res Clin Pract. 2004 Aug;65(2):85-93
pubmed: 15223220
J Med Virol. 2020 Jul;92(7):719-725
pubmed: 32170865
Bioinformation. 2014 Aug 30;10(8):533-8
pubmed: 25258490
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Scand J Med Sci Sports. 1998 Apr;8(2):91-7
pubmed: 9564713
Eur J Public Health. 2006 Apr;16(2):179-84
pubmed: 16126743
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Front Aging Neurosci. 2013 Nov 12;5:75
pubmed: 24282403
Neuro Endocrinol Lett. 2005 Aug;26(4):361-6
pubmed: 16136008
Front Physiol. 2020 Jan 24;10:1602
pubmed: 32038286
Ann Allergy. 1990 Oct;65(4):304-10
pubmed: 2221489
Eur J Appl Physiol. 2018 Feb;118(2):331-338
pubmed: 29209783
Front Biosci. 2008 Jan 01;13:1227-39
pubmed: 17981625
Front Physiol. 2019 Sep 03;10:1123
pubmed: 31551806
Psychol Aging. 2013 Jun;28(2):587-94
pubmed: 23795769
Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8738-43
pubmed: 26124093
PLoS One. 2014 Nov 11;9(11):e112892
pubmed: 25386658
Clin Immunol. 2012 Aug;144(2):142-58
pubmed: 22771788
Med Sci Sports Exerc. 2014 Apr;46(4):711-7
pubmed: 24002349
Trials. 2017 Jun 2;18(1):250
pubmed: 28578691
Pulm Pharmacol Ther. 2007;20(2):130-4
pubmed: 16702004
Transl Psychiatry. 2017 Dec 8;7(12):1268
pubmed: 29217840
Int J Lab Hematol. 2010 Feb;32(1 Pt 2):117-21
pubmed: 19196379
Crit Care. 2012 Oct 18;16(5):R199
pubmed: 23078757
J Infect Dis. 2017 Jun 15;215(12):1807-1815
pubmed: 28472421
J Psychol. 2019;153(1):102-125
pubmed: 30321106
Oncotarget. 2018 Mar 30;9(24):17181-17198
pubmed: 29682215
J Exerc Rehabil. 2019 Aug 28;15(4):566-570
pubmed: 31523678
J Phys Ther Sci. 2017 Aug;29(8):1454-1457
pubmed: 28878482
Brain Behav Immun. 2011 Feb;25(2):221-9
pubmed: 20955778
Cell Physiol Biochem. 2015;37(1):162-75
pubmed: 26303678
Lancet Respir Med. 2020 Mar;8(3):e11-e12
pubmed: 32061335
Front Immunol. 2018 Apr 13;9:754
pubmed: 29706967
JAMA. 2020 Feb 25;323(8):707-708
pubmed: 31971553
J Sport Health Sci. 2019 May;8(3):201-217
pubmed: 31193280
Respir Med. 2014 Dec;108(12):1779-85
pubmed: 25448311
Front Aging Neurosci. 2019 Apr 26;11:98
pubmed: 31080412
Adv Exp Med Biol. 2019;1197:107-117
pubmed: 31732938
J Infect Dis. 2018 Sep 8;218(8):1249-1260
pubmed: 29846635
Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1868-73
pubmed: 15284086
J Appl Physiol (1985). 2013 Jan 1;114(1):66-72
pubmed: 23104690
Respir Med. 2009 Oct;103(10):1503-10
pubmed: 19464865
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5
pubmed: 24599590
Phys Ther. 2008 Nov;88(11):1254-64
pubmed: 18801858
Physiol Behav. 2007 Feb 28;90(2-3):394-404
pubmed: 17113610
Front Immunol. 2020 Mar 19;11:409
pubmed: 32265910
J Vet Intern Med. 1996 Sep-Oct;10(5):280-9
pubmed: 8884712
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Sports Health. 2014 May;6(3):225-31
pubmed: 24790692
Vet World. 2019 Oct;12(10):1554-1562
pubmed: 31849416
Eur Respir J. 2009 Feb;33(2):382-8
pubmed: 19010993
Respir Med. 2013 May;107(5):684-90
pubmed: 23485096
Int J Mol Sci. 2019 Jul 10;20(14):
pubmed: 31295952
Clinics (Sao Paulo). 2008 Dec;63(6):753-8
pubmed: 19060996
Psychiatry Res. 2020 Jun;288:112954
pubmed: 32325383
Exerc Sport Sci Rev. 2009 Oct;37(4):157-64
pubmed: 19955864
J Innate Immun. 2018;10(4):279-290
pubmed: 29843140
Am J Med. 2010 Mar;123(3):281.e7-281.e11
pubmed: 20193839
J Virol. 2010 Feb;84(3):1289-301
pubmed: 19906920
J Appl Physiol (1985). 2015 Jul 15;119(2):124-34
pubmed: 25997943
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Eur Respir J. 2012 Feb;39(2):254-64
pubmed: 21700603
Cardiovasc Res. 2002 Apr;54(1):162-74
pubmed: 12062372
Acta Anaesthesiol Scand. 2004 Jan;48(1):93-101
pubmed: 14674979
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Int J Chron Obstruct Pulmon Dis. 2015 Nov 23;10:2549-57
pubmed: 26648712
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Respir Physiol Neurobiol. 2011 Mar 15;175(3):383-9
pubmed: 21236366
Exerc Immunol Rev. 2018;24:36-44
pubmed: 29461970
Sci China Life Sci. 2018 Oct;61(10):1280-1282
pubmed: 30091015
Expert Rev Respir Med. 2014 Feb;8(1):25-42
pubmed: 24325586
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Eur J Appl Physiol. 2007 Nov;101(5):539-46
pubmed: 17668230
Physiol Rev. 2000 Jul;80(3):1055-81
pubmed: 10893431
J Sports Sci Med. 2012 Dec 01;11(4):638-42
pubmed: 24150073
PLoS One. 2019 Jun 6;14(6):e0217626
pubmed: 31170203
Curr Drug Targets Inflamm Allergy. 2004 Dec;3(4):455-8
pubmed: 15584894
Life Sci. 2013 Feb 27;92(3):218-27
pubmed: 23295959
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814
Med Intensiva. 2014 Mar;38(2):73-82
pubmed: 23485500